Rein Therapeutics, Inc. (RNTX)
Rein Therapeutics Inc. operates as a clinical-stage biopharmaceutical enterprise focused on discovering and bringing to market novel therapeutic solutions for various conditions, notably cancer. The company's leading drug candidate, ALRN-6924, is a distinctive cell-penetrating peptide. This compound works by disrupting the harmful interaction between the p53 suppressor proteins, MDM2 and MDMX, and the vital p53 tumor suppressor. Its goal is to reactivate the natural tumor-suppressing pathways in cancers where the p53 gene is still functional, or "wild-type." The organization was founded on August 6, 2001, by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky, and its main corporate offices are situated in Austin, Texas.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Rein Therapeutics Inc.
NASDAQ:RNTXHealthcare · Biotechnology
-7.79%$0.6700
AH$0.6700+0.00%vs close
Mkt Cap$57.8M
Float86.18M
O/S86.27M
Vol
$ Vol
RVOL
Inst Own47.2%
SI0.7%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$49.87M
Total Assets$24.16M
Free Cash Flow-$19.36M
Debt & Equity
Equity 27%
Preferred 73%
Total Debt$0
Total Equity$16.92M
Preferred Stock$45.01M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in RNTX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$24.16M
Liabilities$7.24M
Accounts Receivable$0
Accounts Payable$3.98M
Inventory$0
PP&E (Net)$0
Goodwill$6.33M
Intangible Assets$13.5M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - |
| Cost of Revenue | $1K | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | -$1K | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - |
| Research and Development | $11.03M | $14.25M | $4K | $18K | $17K | $11K |
| Selling, General, and Administrative | $10.9M | $13.86M | $11K | $10K | $10K | $9K |
| Other | -$1K | $37M | $928 | $0 | $0 | $0 |
| Total Operating Expenses | $21.93M | $65.11M | $16K | $28K | $27K | $20K |
| Operating Income (EBIT) | -$21.93M | -$65.11M | -$16K | -$28K | -$27K | -$20K |
| Operating Margin | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $400K | $600 | $0 | $0 | $0 |
| Other Income (Expense) | -$28.65M | $800K | $544 | $318 | $441 | -$661 |
| Income Before Tax (EBT) | -$50.58M | -$64.31M | -$16K | -$27K | -$26K | -$21K |
| Income Tax Expense | -$712K | -$1.54M | $0 | $0 | $0 | $0 |
| Net Income | -$49.87M | -$62.88M | -$16K | -$27K | -$26K | -$21K |
| Net Income Margin | - | - | - | - | - | - |
| Supplementary Data | ||||||
| EPS | -1.96 | -3.51 | -3.42 | -6.02 | -5.89 | -0.00 |
| Diluted EPS | -1.96 | -3.51 | -3.42 | -6.02 | -5.89 | -0.00 |
| Weighted Average OS | 25.44M | 17.94M | 4.60M | 4.54M | 4.44M | 17.43M |
| EBITDA | -$50.58M | -$28.05M | $104K | $142K | $95K | $143K |
| EBITDA Margin | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $3.21M | $12.87M | $17.31M | $5.19M | $3.6M | $7.05M | $5.31M | $10.63M | $11.86M | $20.71M | $3.77M |
| Short-Term Investments | $0 | $0 | $0 | $16.05M | $42.33M | $6.76M | $12.97M | $10.06M | $38.89M | $0 | $0 |
| Cash and Short-Term Investments | $3.21M | $12.87M | $17.31M | $21.24M | $45.93M | $13.8M | $18.28M | $20.7M | $50.75M | $20.71M | $3.77M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $881K | $676K | $746K | $631K | $25K | $593K | $25K | $25K | $88K | $25K | $0 |
| Total Current Assets | $4.33M | $13.66M | $18.27M | $21.87M | $48.18M | $16.33M | $19.55M | $21.77M | $51.84M | $21.07M | $4.03M |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $0 | $1K | $19K | $110K | $280K | $15K | $6.36M | $7.29M | $154K | $107K | $351K |
| Goodwill | $6.33M | $0 | $6.33M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $13.5M | $48.53M | $79.2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $7.05M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $2K | $2K | $2.19M | $24K | $24K | $0 | $568K | $1.25M | $694K | $841K | $1.56M |
| Total Long-Term Assets | $19.83M | $55.58M | $87.74M | $134K | $304K | $15K | $6.92M | $8.54M | $848K | $948K | $1.91M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $24.16M | $69.24M | $106.01M | $22.01M | $48.48M | $16.34M | $26.47M | $30.31M | $52.69M | $22.02M | $5.94M |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $3.98M | $911K | $1.19M | $1.72M | $1.21M | $1.6M | $1.45M | $1.73M | $1.6M | $1.97M | $641K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $168K | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $98K | $3.36M | $206K | $181K | $60K | $243K | $352K | $423K | $351K | $1.05M | $176K |
| Total Current Liabilities | $6.18M | $5.75M | $4.38M | $3.38M | $4.51M | $3.96M | $5.84M | $5.37M | $4.89M | $4.07M | $2.55M |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $219K | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $1.06M | $8.82M | $3.33M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $277K | $91.41M | $0 | $0 | $0 | $0 | $0 | $0 | $129.76M | $97.71M |
| Total Long-Term Liabilities | $1.06M | $9.1M | $94.74M | $0 | $69K | $219K | $4.59M | $5.34M | $0 | $129.76M | $97.71M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $7.24M | $14.85M | $99.12M | $3.38M | $4.58M | $4.18M | $10.43M | $10.71M | $4.89M | $133.83M | $100.26M |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $45.01M | $45.01M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $113K | $108K | $91K | $91K | $91K | $44K | $28K | $15K | $15K | $0 | $0 |
| Retained Earnings | -$401.27M | -$351.4M | -$288.52M | -$272.79M | -$245.46M | -$219.29M | -$198.13M | -$168.49M | -$136.95M | -$114.34M | -$96.22M |
| Comprehensive Income & Other | -$62K | -$18K | -$63K | -$48K | -$13K | -$2K | $7K | -$5K | -$33K | $0 | $0 |
| Other Stockholders' Equity | $418.08M | $405.68M | $295.31M | $291.32M | $289.27M | $231.41M | $214.16M | $188.08M | $184.73M | $2.54M | $1.9M |
| Total Equity | $16.92M | $54.39M | $6.89M | $18.62M | $43.9M | $12.16M | $16.05M | $19.6M | $47.8M | -$111.81M | -$94.32M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $24.16M | $69.24M | $106.01M | $22.01M | $48.48M | $16.34M | $26.47M | $30.31M | $52.69M | $22.02M | $5.94M |
| Supplementary Data | |||||||||||
| Total Debt | $0 | $0 | $48K | $33K | $162K | $387K | $5.03M | $5.34M | $0 | $0 | $0 |
| Net Debt | -$3.21M | -$12.87M | -$17.27M | -$5.16M | -$3.44M | -$6.66M | -$279K | -$5.29M | -$11.86M | -$20.71M | -$3.77M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Operating Activities | |||||||||||
| Net Income | -$49.87M | -$62.88M | -$15.73M | -$27.33M | -$26.16M | -$21.16M | -$29.37M | -$31.55M | -$22.6M | -$18.12M | -$12.88M |
| Depreciation & Amortization | $1K | $63K | $119K | $169K | $121K | $163K | $155K | $218K | $129K | $232K | $325K |
| Deferred Income Tax | -$712K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $2.22M | $1.12M | $1.19M | $2.08M | $2.26M | $1.89M | $2.12M | $3.28M | $1.75M | $688K | $626K |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $3.06M | -$279K | -$4.98M | $510K | -$386K | $116K | -$277K | $130K | -$241K | $1.22M | -$237K |
| Other Working Capital | -$3.93M | $2.69M | -$399K | -$90K | $628K | -$1.4M | $1.13M | $246K | $588K | -$520K | $475K |
| Total Working Capital Change | -$865K | $2.41M | -$5.38M | $420K | $242K | -$1.28M | $850K | $376K | $347K | $695K | $238K |
| Other Non-Cash Items | $29.86M | $37M | -$4K | -$208K | -$213K | -$95K | -$226K | -$253K | -$152K | $1.49M | -$21K |
| Net Cash from Operating | -$19.36M | -$22.29M | -$19.81M | -$24.86M | -$23.75M | -$20.48M | -$26.47M | -$27.93M | -$20.53M | -$15.01M | -$11.71M |
| Investing Activities | |||||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | -$157K | -$5K | -$151K | -$4.42M | -$142K | $0 | -$94K |
| Acquisitions | $0 | $0 | -$96K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | -$21.85M | -$73.58M | -$10.03M | -$27.24M | -$31.19M | -$71.06M | -$12.63M | -$2.37M |
| Sales of Investments | $0 | $0 | $16.25M | $48.31M | $37.75M | $16.24M | $24.57M | $60.3M | $32.29M | $12.63M | $12.38M |
| Other Investing Activities | $0 | $0 | $42K | $0 | $66K | $208K | $0 | $0 | $0 | -$25K | $713K |
| Net Cash from Investing | $0 | $0 | $16.2M | $26.46M | -$35.92M | $6.41M | -$2.81M | $24.69M | -$38.91M | -$25K | $10.63M |
| Financing Activities | |||||||||||
| Debt Repaid | - | - | - | - | - | -$387K | - | -$2.47M | - | - | - |
| Common Stock Issuance | $9.76M | $10.64M | $0 | $0 | $55.58M | $15.41M | $23.8M | $0 | $52.31M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$91K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $7.17M | $15.79M | $0 | $74K | $0 | $165K | $42K | -$2.19M | -$157K | -$1.27M |
| Net Cash from Financing | $9.76M | $17.82M | $15.79M | $0 | $55.66M | $15.8M | $23.96M | $2.52M | $50.59M | $31.99M | -$1.36M |
| Forex Effect | -$44K | $0 | -$63K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$9.65M | -$4.47M | $12.12M | $1.59M | -$4.01M | $1.74M | -$5.32M | -$723K | -$8.85M | $16.95M | -$2.44M |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$19.36M | -$22.29M | -$19.81M | -$24.86M | -$23.75M | -$20.48M | -$26.47M | -$27.93M | -$20.53M | -$15.01M | -$11.71M |
| Capital Expenditure | $0 | $0 | $0 | $0 | -$157K | -$5K | -$151K | -$4.42M | -$142K | $0 | -$94K |
| Free Cash Flow | -$19.36M | -$22.29M | -$19.81M | -$24.86M | -$23.91M | -$20.48M | -$26.63M | -$32.35M | -$20.67M | -$15.01M | -$11.8M |
| Cash at Beginning | $12.87M | $17.34M | $5.22M | $3.63M | $7.64M | $5.9M | $11.23M | $11.95M | $20.8M | $3.77M | $6.21M |
| Cash at End | $3.21M | $12.87M | $17.34M | $5.22M | $3.63M | $7.64M | $5.9M | $11.23M | $11.95M | $20.71M | $3.77M |